NASDAQ
Aprea Therapeutics, Inc. (APRE) has a current ratio of 5.63x as of Monday, May 25, 2026. This represents a 23.16% decrease compared to its 12-month average of 7.33x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.